DelShad is built on evidence-based research and validated cardiovascular risk assessment models. Learn about the science behind our platform.
SCORE2 is the latest cardiovascular risk prediction model developed by the European Society of Cardiology. It provides accurate 10-year risk estimates for fatal and non-fatal cardiovascular events, including myocardial infarction and stroke.
SCORE2 has been validated in multiple large-scale European studies involving over 1.3 million individuals. The model shows excellent calibration and discrimination, making it the gold standard for cardiovascular risk assessment in Europe.
Reference: SCORE2 working group and ESC Cardiovascular Risk Collaboration. (2021). SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. European Heart Journal.
The World Health Organization (WHO) has developed cardiovascular risk prediction charts for different world regions. These charts are specifically designed for use in settings where laboratory facilities may be limited, providing a practical tool for risk assessment in diverse healthcare environments.
WHO CVD Risk Charts are designed to be simple, practical, and applicable in resource-limited settings. They use non-laboratory-based risk factors (age, sex, smoking status, diabetes status, and blood pressure) to estimate cardiovascular risk, making them accessible to a wider range of healthcare providers and patients.
Reference: World Health Organization. (2019). WHO CVD Risk Chart Working Group. World Health Organization Cardiovascular Disease Risk Charts: Revised models to estimate risk in 21 global regions.
DelShad integrates SCORE2 and WHO CVD Risk Charts into a user-friendly mobile application, making evidence-based cardiovascular risk assessment accessible to everyone. Our research focuses on improving the usability and effectiveness of digital health interventions for cardiovascular disease prevention.
Research on mobile health applications for cardiovascular disease prevention and their impact on patient engagement and health outcomes.
Validation studies comparing DelShad's risk predictions with clinical outcomes and traditional risk assessment methods.
Studies on how DelShad can be integrated into clinical practice to support healthcare providers in cardiovascular risk management.
SCORE2 working group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. European Heart Journal, 2021; 42(25): 2439-2454.
World Health Organization. WHO CVD Risk Chart Working Group. World Health Organization Cardiovascular Disease Risk Charts: Revised models to estimate risk in 21 global regions. Lancet Global Health, 2019; 7(10): e1332-e1345.
Research on mobile health applications and their effectiveness in cardiovascular disease prevention. Ongoing studies at Tehran Heart Center and Primary Prevention of Cardiovascular Diseases Research Center.